218 related articles for article (PubMed ID: 27084651)
1. Practice Patterns Analysis of Ocular Proton Therapy Centers: The International OPTIC Survey.
Hrbacek J; Mishra KK; Kacperek A; Dendale R; Nauraye C; Auger M; Herault J; Daftari IK; Trofimov AV; Shih HA; Chen YE; Denker A; Heufelder J; Horwacik T; Swakoń J; Hoehr C; Duzenli C; Pica A; Goudjil F; Mazal A; Thariat J; Weber DC
Int J Radiat Oncol Biol Phys; 2016 May; 95(1):336-343. PubMed ID: 27084651
[TBL] [Abstract][Full Text] [Related]
2. Design and commissioning of the non-dedicated scanning proton beamline for ocular treatment at the synchrotron-based CNAO facility.
Ciocca M; Magro G; Mastella E; Mairani A; Mirandola A; Molinelli S; Russo S; Vai A; Fiore MR; Mosci C; Valvo F; Via R; Baroni G; Orecchia R
Med Phys; 2019 Apr; 46(4):1852-1862. PubMed ID: 30659616
[TBL] [Abstract][Full Text] [Related]
3. Characterization of the HollandPTC proton therapy beamline dedicated to uveal melanoma treatment and an interinstitutional comparison.
Fleury E; Trnková P; Spruijt K; Herault J; Lebbink F; Heufelder J; Hrbacek J; Horwacik T; Kajdrowicz T; Denker A; Gerard A; Hofverberg P; Mamalui M; Slopsema R; Pignol JP; Hoogeman M
Med Phys; 2021 Aug; 48(8):4506-4522. PubMed ID: 34091930
[TBL] [Abstract][Full Text] [Related]
4. Clinical application of proton beams in the treatment of uveal melanoma: the first therapies carried out in Italy and preliminary results (CATANA Project).
Spatola C; Privitera G; Raffaele L; Salamone V; Cuttone G; Cirrone P; Sabini MG; Lo Nigro S
Tumori; 2003; 89(5):502-9. PubMed ID: 14870772
[TBL] [Abstract][Full Text] [Related]
5. Proton therapy for uveal melanomas and other eye lesions.
Munzenrider JE
Strahlenther Onkol; 1999 Jun; 175 Suppl 2():68-73. PubMed ID: 10394402
[TBL] [Abstract][Full Text] [Related]
6. Proton therapy in ophthalmology: status report and problems encountered.
Chauvel P; Iborra-Brassart N; Courdi A; Hérault J; Teissier E; Pignol JP; Bondiau PY
Bull Cancer Radiother; 1996; 83 Suppl():215s-8s. PubMed ID: 8949783
[TBL] [Abstract][Full Text] [Related]
7. Dosimetry for ocular proton beam therapy at the Harvard Cyclotron Laboratory based on the ICRU Report 59.
Newhauser WD; Burns J; Smith AR
Med Phys; 2002 Sep; 29(9):1953-61. PubMed ID: 12349914
[TBL] [Abstract][Full Text] [Related]
8. Temporal Evolution and Dose-Volume Histogram Predictors of Visual Acuity After Proton Beam Radiation Therapy of Uveal Melanoma.
Polishchuk AL; Mishra KK; Weinberg V; Daftari IK; Nguyen JM; Cole TB; Quivey JM; Phillips TL; Char DH
Int J Radiat Oncol Biol Phys; 2017 Jan; 97(1):91-97. PubMed ID: 27838186
[TBL] [Abstract][Full Text] [Related]
9. Proton therapy of uveal melanomas: intercomparison of MRI-based and conventional treatment planning.
Marnitz S; Cordini D; Bendl R; Lemke AJ; Heufelder J; Simiantonakis I; Kluge H; Bechrakis NE; Foerster MH; Hinkelbein W
Strahlenther Onkol; 2006 Jul; 182(7):395-9. PubMed ID: 16826358
[TBL] [Abstract][Full Text] [Related]
10. Proton beam radiotherapy versus fractionated stereotactic radiotherapy for uveal melanomas: A comparative study.
Weber DC; Bogner J; Verwey J; Georg D; Dieckmann K; Escudé L; Caro M; Pötter R; Goitein G; Lomax AJ; Miralbell R
Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):373-84. PubMed ID: 16168832
[TBL] [Abstract][Full Text] [Related]
11. Modernization of safety environment for a dedicated beamline for proton ocular therapy.
Jee KW; Verburg JM; Ruggieri TA; Bussière M; Trofimov AV
Med Phys; 2023 Nov; 50(11):7093-7103. PubMed ID: 37782071
[TBL] [Abstract][Full Text] [Related]
12. Quality of life and treatment-related burden during ocular proton therapy: a prospective trial of 131 patients with uveal melanoma.
Gollrad J; Rabsahl C; Riechardt AI; Heufelder J; Stroux A; Goerling U; Joussen A; Budach V; Boehmer D
Radiat Oncol; 2021 Sep; 16(1):174. PubMed ID: 34496895
[TBL] [Abstract][Full Text] [Related]
13. Estimates of ocular and visual retention following treatment of extra-large uveal melanomas by proton beam radiotherapy.
Conway RM; Poothullil AM; Daftari IK; Weinberg V; Chung JE; O'Brien JM
Arch Ophthalmol; 2006 Jun; 124(6):838-43. PubMed ID: 16769837
[TBL] [Abstract][Full Text] [Related]
14. Ocular proton therapy, pencil beam scanning high energy proton therapy or stereotactic radiotherapy for uveal melanoma; an in silico study.
Gerard A; Peyrichon ML; Vidal M; Barnel C; Sauerwein W; Carnicer A; Angellier G; Mathis TM; Mishra KK; Thariat J; Herault J
Cancer Radiother; 2022 Nov; 26(8):1027-1033. PubMed ID: 35803862
[TBL] [Abstract][Full Text] [Related]
15. An improved treatment planning and quality assurance process for Collaborative Ocular Melanoma Study eye plaque brachytherapy.
Weersink RA; Patterson S; Ballantyne H; Di Tomasso A; Borg J; Vitkin A; Rink A; Beiki-Ardakani A
Brachytherapy; 2019; 18(5):658-667. PubMed ID: 31235445
[TBL] [Abstract][Full Text] [Related]
16. Patterns of care and follow-up care of patients with uveal melanoma in German-speaking countries: a multinational survey of the German Dermatologic Cooperative Oncology Group (DeCOG).
Steeb T; Wessely A; Alter M; Bayerl C; Bender A; Bruning G; Dabrowski E; Debus D; Devereux N; Dippel E; Drexler K; Dücker P; Dummer R; Emmert S; Elsner P; Enk A; Gebhardt C; Gesierich A; Goebeler M; Goerdt S; Goetze S; Gutzmer R; Haferkamp S; Hansel G; Hassel JC; Heinzerling L; Kähler KC; Kaume KM; Krapf W; Kreuzberg N; Lehmann P; Livingstone E; Löffler H; Loquai C; Mauch C; Mangana J; Meier F; Meissner M; Moritz RKC; Maul LV; Müller V; Mohr P; Navarini A; Van Nguyen A; Pfeiffer C; Pföhler C; Posch C; Richtig E; Rompel R; Sachse MM; Sauder S; Schadendorf D; Schatton K; Schulze HJ; Schultz E; Schilling B; Schmuth M; Simon JC; Streit M; Terheyden P; Thiem A; Tüting T; Welzel J; Weyandt G; Wesselmann U; Wollina U; Ziemer M; Zimmer L; Zutt M; Berking C; Schlaak M; Heppt MV;
J Cancer Res Clin Oncol; 2021 Jun; 147(6):1763-1771. PubMed ID: 33219855
[TBL] [Abstract][Full Text] [Related]
17. Development and long-term stability of a comprehensive daily QA program for a modern pencil beam scanning (PBS) proton therapy delivery system.
Rana S; Bennouna J; Samuel EJJ; Gutierrez AN
J Appl Clin Med Phys; 2019 Apr; 20(4):29-44. PubMed ID: 30920146
[TBL] [Abstract][Full Text] [Related]
18. Profile of European proton and carbon ion therapy centers assessed by the EORTC facility questionnaire.
Weber DC; Abrunhosa-Branquinho A; Bolsi A; Kacperek A; Dendale R; Geismar D; Bachtiary B; Hall A; Heufelder J; Herfarth K; Debus J; Amichetti M; Krause M; Orecchia R; Vondracek V; Thariat J; Kajdrowicz T; Nilsson K; Grau C
Radiother Oncol; 2017 Aug; 124(2):185-189. PubMed ID: 28764925
[TBL] [Abstract][Full Text] [Related]
19. [Treatment of eye tumors by accelerated proton beams. 7 years experience].
Zografos L; Bercher L; Egger E; Chamot L; Gailloud C; Uffer S; Perret C; Markovits C
Klin Monbl Augenheilkd; 1992 May; 200(5):431-5. PubMed ID: 1319524
[TBL] [Abstract][Full Text] [Related]
20. Proton therapy for the management of uveal melanoma and other ocular tumors.
Mishra KK; Daftari IK
Chin Clin Oncol; 2016 Aug; 5(4):50. PubMed ID: 27558251
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
